CYP2E1 and tuberculosis: Population-Specific Pharmacogenomic Profiling of &lt;i&gt;NAT2&lt;/i&gt;, &lt;i&gt;CYP2E1&lt;/i&gt;, and &lt;i&gt;SLCO1B1&lt;/i&gt; in Tuberculosis Patients from Southern Peru: A Feasibility Pilot Study.